Roivant Sciences (ROIV) Liabilities and Shareholders Equity (2021 - 2026)
Roivant Sciences' Liabilities and Shareholders Equity was $5.31 billion in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 5.4% from $5.03 billion a year earlier but down 7.0% from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Liabilities and Shareholders Equity at Roivant Sciences came in at $5.71 billion, up 5.0% from FY2025.
- Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 17.1% (FY2021 to FY2026).
- In earlier fiscal years, Liabilities and Shareholders Equity was $5.44 billion in FY2025 (-24.7%), $7.22 billion in FY2024 (+202.2%), $2.39 billion in FY2023 (-7.6%) and $2.59 billion in FY2022 (-0.2%).
- Quarterly Liabilities and Shareholders Equity has moved between $2.07 billion (fiscal Q2 2024) and $7.31 billion (fiscal Q3 2024) over five years.
- Compared with a year earlier, Liabilities and Shareholders Equity was higher in three of the last eight quarters, with growth averaging 14.3%.
- The best year-over-year quarter for Liabilities and Shareholders Equity over five years was fiscal Q3 2024 (growth of 231.9%); the worst was fiscal Q2 2023 (a decline of 28.6%).
- Per Business Quant data, ROIV's Liabilities and Shareholders Equity in the three fiscal quarters before Q1 2027 was $5.71 billion (Q4 2026), $5.23 billion (Q3 2026) and $5.06 billion (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Roivant Sciences | 26.43 Bn | 27.12 Bn | 1.16 Mn | 5.31 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.31 Bn |
| Mar 31, 2026 | 5.71 Bn |
| Dec 31, 2025 | 5.23 Bn |
| Sep 30, 2025 | 5.06 Bn |
| Jun 30, 2025 | 5.03 Bn |
| Mar 31, 2025 | 5.44 Bn |
| Dec 31, 2024 | 5.79 Bn |
| Sep 30, 2024 | 6.21 Bn |
| Jun 30, 2024 | 6.50 Bn |
| Mar 31, 2024 | 7.22 Bn |
| Dec 31, 2023 | 7.31 Bn |
| Sep 30, 2023 | 2.07 Bn |
| Jun 30, 2023 | 2.14 Bn |
| Mar 31, 2023 | 2.39 Bn |
| Dec 31, 2022 | 2.20 Bn |
| Sep 30, 2022 | 2.22 Bn |
| Jun 30, 2022 | 2.60 Bn |
| Mar 31, 2022 | 2.59 Bn |
| Dec 31, 2021 | 2.80 Bn |
| Sep 30, 2021 | 3.10 Bn |
API Access
Roivant Sciences Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();